31 TL PRECISION AQ - From insight to impact

PRECISION AQ - From insight to impact: strengthening stakeholder engagement across the patient journey

27 TL Aspire Pharma – enhancing the patient experience through stakeholder engagement

Aspire Pharma – enhancing the patient experience through stakeholder engagement. ‘Equipping HCPs with the right tools, resources and knowledge is essential in removing barriers to care’

23 TL JPA - A quest for the crown: ruling digital relevance in the age of LLMs

A quest for the crown: ruling digital relevance in the age of LLMs. It’s not just about driving clicks and search engine rankings – it’s about shaping the conversation itself.

18-19 US TARIFFS ON PHARMA - The impact of US tariffs on healthcare and life sciences multinationals

CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value

24 TL VEEVA - Biopharma 2030 challenge: scaling product launches without growing teams

31Obsidian - Maximising impact in medical communications: where are we now and where are we heading?

16-17 The three non-negotiable pillars of Alzheimer’s blood testing

The three non-negotiable pillars of Alzheimer’s blood testing. Why sensitivity, access and education will define scalable Alzheimer’s diagnostics

18-19 Physician-driven, AI-supported: addressing the clinical trial access gap

Physician-driven, AI-supported: addressing the clinical trial access gap. To open up more clinical paths for patients, HCPs need simpler search tools, better access to information and integrated referral systems that fit into their clinical workflows

28-30 Navigating the ‘Patient Metro’ – a journey full of insights

Navigating the ‘Patient Metro’ – a journey full of insights. The key to unravelling its potential is to focus on the intersections where journeys are made or broken

32-33 GenAI tools – creating a new era of scientific research

GenAI tools – creating a new era of scientific research. The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed

24-25 From disruption to resilience: India’s growing role in pharma logistics

From disruption to resilience: India’s growing role in pharma logistics. In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever

20-22 A new advent of clinical pathway management

A new advent of clinical pathway management. Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials

35 - HEALTHCARE COMMS

New mental health support campaign, Minds on Matters, launched • SAY Communications selects Overcoming MS for its pro bono programme

25 TL KANGA - Launch excellence: innovative thinking meets insightful strategy

28 TL SPROUT HEALTH - What does it mean to improve outcomes for patients with chronic

26-27 LAUNCH EXCELLENCE - Will data and AI prove to be the game-changer that transforms

39 - HEALTHCRAE COMMS

33-35 HEALTHCARE COMMS – Setting the direction – how exemplary brand teams brief their agency partn

‘Patient engagement is both a process and a behaviour throughout the drug life cycle’

38 Appointments

PME October 2025 - Appointments

37 Appointments

PME October 2025 Appointments

36 Appointments

PME October 2025 Appointments

36 Appointments

37 Appointments

43 Appointments